VanEck Pharmaceutical ETF
PPHNASDAQVanEckEquity
As of Oct 23, 2026 close
- Assets (AUM)
- $1.05B
- Expense ratio
- 0.36%
- Dividend yield
- 1.83%
- Holdings
- 26
- 52-week range
- $90.74$118.00
- Volume (live)
- -
- Avg. volume (3M)
- 359.90K
PPH ETF: VanEck Pharmaceutical ETF - Price, Holdings & Analysis
VanEck Pharmaceutical ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $114.53 - $116.68 |
|---|---|
| 52-Week High | $118.00 |
| 52-Week Low | $90.74 |
| Open | $116.68 |
| Volume (last close) | 229.06K |
| Average Volume (3M) | 359.90K |
| 1 Day Change | +1.26% |
|---|---|
| 1 Month Change | +6.11% |
| 6 Month Change | +15.54% |
| YTD Change | +12.84% |
| 1 Year Change | +26.54% |
| 5 Year Change | +56.91% |
| 10 Year Change | +112.45% |
| Annual Dividend | $2.14 |
|---|---|
| Dividend Yield | 1.83% |
| Last Dividend Ex-Date | Oct 1, 2026 |
| Dividend Growth YoY | +10.53% |
| Years Dividend Growth | 3 |
| Assets (AUM) | $1.05B |
|---|---|
| Expense Ratio | 0.36% |
| Total Holdings | 26 |
| Inception Date | Jan 31, 2000 |
| 50-Day MA | $112.09 |
|---|---|
| 200-Day MA | $107.49 |
| RSI | 66.12 |
| Stochastic %K | 96.54 |
| Stochastic %D | 84.70 |
Source: Exchange price data and fund disclosures. Data as of Oct 23, 2026. Data sources and methodology
PPH at a Glance
VanEck Pharmaceutical ETF (PPH) is an equity ETF from VanEck, launched in January 2000. It manages $1.05B in assets and charges a 0.36% expense ratio, about $36 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 26 positions. The largest are Eli Lilly and Company (LLY, 20.69%), Merck & Co., Inc. (MRK, 13.39%) and Novartis AG (NVS, 9.32%). The top 10 holdings make up 78.0% of the fund. By sector it leans toward Healthcare (100.0%). Its largest country exposures are United States (61.7%), United Kingdom (11.3%) and Switzerland (10.3%).
It pays distributions yielding 1.83% at the Oct 23, 2026 close, $2.14 per share over the trailing 12 months. As of the Oct 23, 2026 close, the share price is up 26.5% over one year, up 56.9% over five years and up 112.5% over ten years (price change, excluding distributions).
Frequently Asked Questions About VanEck Pharmaceutical ETF
What is the current price of PPH?
The latest PPH price is $114.93 (Oct 23, 2026 close). The 52-week range is $90.74–$118.00. The share price is up 26.5% over the past year (price change, excluding distributions).
What is the expense ratio for PPH?
PPH's annual expense ratio is 0.36%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does PPH pay dividends?
Yes, PPH pays a 1.83% dividend yield (trailing 12 months, at the Oct 23, 2026 close). The most recent ex-dividend date was October 1, 2026. View full dividend history in the Dividends section.
What are the top holdings of PPH?
As of Oct 4, 2026, PPH's largest holdings are Eli Lilly and Company (20.7%), Merck & Co., Inc. (13.4%), Novartis AG (9.3%) (combined weight: 43.4%). The fund holds 26 total positions. View the complete portfolio breakdown in the Holdings section.
How does PPH compare to similar ETFs?
Compare PPH (0.36% expense ratio, $1.05B AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.